Source
|
ENCEPHALE (n°2 vol 47)
|
Auteur(s) :
|
VEYRIER M, Aut. ; ARIOUAT I, Aut. ; JACOB A, Aut. ; TROUT H, Aut. ; BLOCH V, Aut. ; DELAVEST M, Aut. ; BELLIVIER Frank, Aut. ; GEOFFROY PA, Aut.
|
Année de publication :
|
2021
|
Pages :
|
96-101
|
Mots-clés :
|
CHRONOBIOLOGIE ;
EFFICACITE ;
INDICE DE MASSE CORPORELLE ;
MELATONINE ;
METABOLISME ;
OBSERVATION ;
TROUBLE DU SOMMEIL ;
|
Résumé :
|
There is a growing interest in psychiatry regarding melatonin use both for its soporific and chronobiotic effects. This study aimed to evaluate factors impacting the daily-dose. In a university department of psychiatry in Paris (France), we conducted a posteriori naturalistic observational study from April 03, 2017 to January 31, 2018. We assessed links between sociodemographic and clinical characteristics and daily dose of melatonin (the daily-dose of melatonin initiation and the daily-dose at Hospital discharge). A survey of drug interactions was performed regarding metabolic inducers and inhibitors of the cytochrome P450 1A2 [Extrait du résumé d'auteur]
|